<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>PIPERAZINE - Research Report</title>
    <meta name="description" content="Comprehensive naturopathic research report for PIPERAZINE">
    <style>

    * {
        box-sizing: border-box;
    }

    body {
        font-family: 'Segoe UI', 'Helvetica Neue', Arial, sans-serif;
        font-size: 16px;
        line-height: 1.6;
        margin: 0;
        padding: 0;
        background-color: #f8f9fa;
        color: #212529;
    }

    .container {
        max-width: 1200px;
        margin: 0 auto;
        padding: 20px;
        background-color: white;
        box-shadow: 0 0 10px rgba(0,0,0,0.1);
    }

    .medication-header {
        background: linear-gradient(135deg, #2c3e50, #003366);
        color: white;
        padding: 30px;
        margin: -20px -20px 30px -20px;
        border-radius: 0 0 10px 10px;
        text-align: center;
        position: relative;
    }

    .medication-header h1 {
        margin: 0 0 15px 0;
        font-size: 2.5em;
        font-weight: 600;
        text-shadow: 0 2px 4px rgba(0,0,0,0.3);
    }

    .status-badge {
        display: inline-block;
        padding: 8px 20px;
        border-radius: 25px;
        font-weight: 600;
        font-size: 0.9em;
        text-transform: uppercase;
        letter-spacing: 1px;
        box-shadow: 0 2px 4px rgba(0,0,0,0.2);
    }

    .status-allowed { background-color: #28a745; color: white; }
    .status-not-allowed { background-color: #dc3545; color: white; }
    .status-modernization { background-color: #fd7e14; color: white; }
    .status-topical { background-color: #20c997; color: white; }
    .status-review { background-color: #ffc107; color: #212529; }
    .status-not-applicable { background-color: #6c757d; color: white; }
    .status-unknown { background-color: #adb5bd; color: white; }

    .natural-connections {
        margin-bottom: 30px;
        padding: 20px;
        background-color: #f8f9fa;
        border-radius: 10px;
        border-left: 4px solid #007bff;
    }

    .natural-connections h2 {
        margin: 0 0 15px 0;
        font-size: 1.4em;
        color: #2c3e50;
    }

    .connection-tags {
        display: flex;
        flex-wrap: wrap;
        gap: 8px;
    }

    .connection-tag {
        display: inline-block;
        padding: 6px 12px;
        border-radius: 15px;
        font-size: 0.85em;
        font-weight: 500;
        color: white;
        white-space: nowrap;
    }

    .tag-direct { background-color: #0d6832; }
    .tag-semi-synthetic { background-color: #198754; }
    .tag-structural { background-color: #0d6efd; }
    .tag-endogenous { background-color: #6610f2; }
    .tag-biosynthetic { background-color: #6f42c1; }
    .tag-pathways { background-color: #0dcaf0; color: #212529; }
    .tag-processes { background-color: #3dd5f3; color: #212529; }

    .report-content {
        line-height: 1.7;
    }

    .report-content h1 {
        color: #2c3e50;
        border-bottom: 3px solid #007bff;
        padding-bottom: 10px;
        margin: 30px 0 20px 0;
    }

    .report-content h2 {
        color: #495057;
        border-bottom: 2px solid #dee2e6;
        padding-bottom: 8px;
        margin: 25px 0 15px 0;
    }

    .report-content h3 {
        color: #6c757d;
        margin: 20px 0 10px 0;
    }

    .report-content p {
        margin-bottom: 15px;
        text-align: justify;
    }

    .checkbox {
        font-weight: bold;
        margin-right: 5px;
    }

    .checkbox.checked { color: #28a745; }
    .checkbox.unchecked { color: #6c757d; }

    .footer {
        margin-top: 40px;
        padding: 20px 0;
        border-top: 1px solid #dee2e6;
        text-align: center;
        color: #6c757d;
        font-size: 0.9em;
    }

    .back-link {
        display: inline-block;
        margin-bottom: 20px;
        padding: 8px 16px;
        background-color: #007bff;
        color: white;
        text-decoration: none;
        border-radius: 5px;
        transition: background-color 0.3s;
    }

    .back-link:hover {
        background-color: #0056b3;
        text-decoration: none;
    }

    @media (max-width: 768px) {
        .container {
            padding: 15px;
            margin: 10px;
        }
        .medication-header {
            margin: -15px -15px 20px -15px;
            padding: 20px;
        }
        .medication-header h1 {
            font-size: 2em;
        }
        .connection-tags {
            justify-content: center;
        }
    }

    @media print {
        .back-link { display: none; }
        .container { box-shadow: none; }
        .medication-header {
            background: #2c3e50 !important;
            -webkit-print-color-adjust: exact;
        }
    }

    </style>
</head>
<body>
    <div class="container">
        <a href="index.html" class="back-link">← Back to Index</a>

        <header class="medication-header">
            <h1>PIPERAZINE</h1>
            <div class="status-badge status-allowed">
                ALLOWED
            </div>
        </header>

        <section class="natural-connections">
            <h2>Natural Connections</h2>
            <div class="connection-tags">
                <span class="connection-tag tag-pathways">Works Natural Pathways</span>
<span class="connection-tag tag-processes">Facilitates Natural Processes</span>
            </div>
        </section>

        <main class="report-content">
            <p>Naturopathic Formulary Medication Evaluation Protocol</p>

<p># Objective: Comprehensive assessment of natural derivation and therapeutic alignment For <strong>PIPERAZINE</strong>: ## <h2>1. NATURAL DERIVATION ASSESSMENT</h2></p>

<p>### <h3>Source Investigation</h3> Piperazine functions as an anthelmintic (anti-parasitic) agent by acting as a GABA (gamma-aminobutyric acid) receptor agonist in parasitic nematodes. Piperazine acts as a GABA receptor agonist specifically in parasitic nematodes, causing hyperpolarization of nerve membranes and resulting in flaccid paralysis. While developed through modern medicinal chemistry, the medication was intentionally crafted to engage these conserved pathways so clinicians can modulate them in a targeted way. Piperazine is a synthetic organic compound first synthesized in 1893 by German chemist Oscar Liebreich. No documentation exists for natural occurrence in plants, animals, fungi, minerals, or marine organisms. The compound is not produced through fermentation or biosynthetic methods from natural sources. Historically, piperazine has been manufactured through synthetic chemical processes involving the reaction of ethylene glycol with ammonia or through cyclization of diethylene glycol diamine.</p>

<h3>Structural Analysis</h3> Piperazine (C₄H₁₀N₂) is a heterocyclic organic compound containing a six-membered ring with two nitrogen atoms in opposite positions. The basic nitrogen atoms in piperazine can form hydrogen bonds similar to those in naturally occurring diamines and some amino acid derivatives.

<h3>Biological Mechanism Evaluation</h3> Piperazine functions as an anthelmintic (anti-parasitic) agent by acting as a GABA (gamma-aminobutyric acid) receptor agonist in parasitic nematodes. This mechanism causes flaccid paralysis of the parasite&#x27;s musculature by blocking neuromuscular transmission. GABA is a naturally occurring inhibitory neurotransmitter in both human and invertebrate nervous systems, representing an evolutionarily conserved signaling pathway.

<h3>Natural System Integration</h3> (Expanded Assessment) Piperazine targets naturally occurring GABA receptors, which are evolutionarily conserved across species and with structural differences between mammals and parasites that allow for selective toxicity. The medication works within established neurotransmitter pathways and removes obstacles to natural healing by eliminating parasitic infections that disrupt normal physiological function. The compound enables the body&#x27;s natural immune and digestive systems to return to homeostatic balance by eliminating parasitic burdens. It provides a targeted intervention that can prevent the need for more invasive treatments or chronic parasitic infections.

<h2>2. THERAPEUTIC CONTEXT</h2>

<p>### Mechanism of Action Piperazine acts as a GABA receptor agonist specifically in parasitic nematodes, causing hyperpolarization of nerve membranes and resulting in flaccid paralysis. This selective action occurs because mammalian and nematode GABA receptors have different structural characteristics, allowing piperazine to preferentially affect parasite nervous systems while having minimal impact on human GABA receptors at therapeutic doses.</p>

<h3>Clinical Utility</h3> Primary therapeutic applications include treatment of roundworm (Ascaris lumbricoides) and pinworm (Enterobius vermicularis) infections. Piperazine has been used for decades as a first-line anthelmintic, particularly in pediatric populations due to its relatively favorable safety profile. It is typically used as a short-term treatment (1-3 days) rather than for chronic administration. The medication has largely been superseded by newer anthelmintics like albendazole and mebendazole in many regions.

<h3>Integration Potential</h3> Piperazine can be integrated into comprehensive naturopathic treatment protocols for parasitic infections, potentially combined with supportive therapies such as probiotics, digestive enzymes, and immune-supporting botanicals. The medication creates a therapeutic window by rapidly eliminating parasites, allowing natural healing processes and gut microbiome restoration to proceed. Practitioner education regarding proper dosing, contraindications, and monitoring for treatment efficacy would be required.

<h2>3. REGULATORY AND PRECEDENT CONTEXT</h2>

<p>### Current Status Piperazine was previously approved by the FDA for human use and is no longer available as a prescription medication in the United States, having been withdrawn due to market factors rather than safety concerns. It remains available in some over-the-counter preparations and is still used in veterinary medicine. The compound is included in the WHO Model List of Essential Medicines for treatment of ascariasis and enterobiasis.</p>

<h3>Comparable Medications</h3> Other anthelmintic medications with different mechanisms of action are included in various formularies, including albendazole and mebendazole (benzimidazole derivatives) and ivermectin (avermectin derivative). These medications share the therapeutic goal of parasite elimination while working through different molecular targets.

<h3>Formulary Precedent Analysis</h3>

<p>This medication aligns with established formulary principles that recognize both naturally-derived and laboratory-produced compounds when they demonstrate therapeutic value and integration with physiological systems. Similar to synthetic hormones already included in the formulary (ethinyl estradiol, levothyroxine), this medication demonstrates that production method works to preclude formulary inclusion when the therapeutic mechanism aligns with natural physiological processes. The precedent established by medications like tretinoin, sucralfate, and cholestyramine supports inclusion of compounds that work through natural pathways regardless of their origin.</p>

<h2>4. COMPREHENSIVE ASSESSMENT</h2> <strong>PIPERAZINE</strong> <p><strong><strong>Evidence Categories Present:</strong></strong></p>

<ul>

<li><span class="checkbox unchecked"><span class="checkbox unchecked">☐</span> </span> Direct natural source</li>

<li><span class="checkbox unchecked"><span class="checkbox unchecked">☐</span> </span> Semi-synthetic from natural precursor</li>

<li><span class="checkbox unchecked"><span class="checkbox unchecked">☐</span> </span> Structural analog of natural compound</li>

<li><span class="checkbox unchecked"><span class="checkbox unchecked">☐</span> </span> Endogenous compound or replacement</li>

<li><span class="checkbox unchecked"><span class="checkbox unchecked">☐</span> </span> Biosynthetic/fermentation product</li>

<li><span class="checkbox checked">✓</span> Works through natural pathways/receptors</li>

<li><span class="checkbox checked">✓</span> Facilitates natural physiological processes</li>

<li><span class="checkbox unchecked"><span class="checkbox unchecked">☐</span> </span> No identified natural connection</li>

</ul><p><strong>Natural Derivation Assessment:</strong></p>

<p>Piperazine is a laboratory-produced compound with laboratory-produced compounds identified. Additionally, it demonstrates significant integration with natural biological systems through its interaction with evolutionarily conserved GABA receptor pathways.</p><p><strong>Structural/Functional Relationships:</strong></p>

<p>While piperazine itself is designed for therapeutic purposes, the piperazine ring system appears in some natural alkaloids and peptides. The compound&#x27;s diamine structure allows for hydrogen bonding patterns similar to those found in naturally occurring diamines.</p><p><strong>Biological Integration:</strong></p>

<p>Piperazine functions through GABA receptor systems that are naturally occurring and evolutionarily conserved. The medication&#x27;s mechanism relies on existing neurotransmitter pathways, demonstrating integration with natural biological systems with its synthetic origin.</p><p><strong>Natural System Interface:</strong></p>

<p>The medication works within naturally occurring GABA neurotransmitter systems, utilizing evolutionarily conserved receptors with selective targeting of parasitic organisms. Piperazine enables restoration of natural physiological balance by eliminating parasitic infections that disrupt normal digestive, immune, and metabolic functions.</p><p><strong>Safety and Therapeutic Profile:</strong></p>

<p>Generally well-tolerated with short-term use. Side effects are typically mild and include gastrointestinal upset, dizziness, and rarely neurological symptoms. Contraindicated in patients with seizure disorders or severe renal impairment. Represents a less invasive alternative to surgical intervention for severe parasitic infections.</p><p><strong>Summary of Findings:</strong></p>

<p>PIPERAZINE provides essential therapeutic benefits through mechanisms that integrate with natural physiological processes. Evidence supports inclusion in the naturopathic formulary based on demonstrated therapeutic efficacy, safety profile, and alignment with principles of supporting natural healing. The medication fills a critical therapeutic need while maintaining compatibility with naturopathic treatment approaches.</p><p><strong><strong>Relevant Citations:</strong></strong></p>

<ol>

<li>DrugBank. &quot;Piperazine&quot; DrugBank Accession Number DB00592. University of Alberta, updated 2024.</li>

<li>World Health Organization. &quot;WHO Model List of Essential Medicines, 23rd List.&quot; Geneva: World Health Organization; 2023. Section 6.1.1 Intestinal anthelminthics.</li>

<li>Martin RJ. &quot;Modes of action of anthelmintic drugs.&quot; Veterinary Journal. 1997;154(1):11-34.</li>

<li>Saz HJ, Weil A. &quot;The mechanism of the neuromuscular blocking action of piperazine on Ascaris muscle.&quot; Journal of Pharmacology and Experimental Therapeutics. 1960;130:112-117.</li>

<li>PubChem. &quot;Piperazine&quot; PubChem CID 4837. National Center for Biotechnology Information, National Library of Medicine.</li>

<li>Holden-Dye L, Walker RJ. &quot;Anthelmintic drugs and nematicides: studies in Caenorhabditis elegans.&quot; WormBook. 2014 Jan 3:1-29.</li>

</ol>
        </main>

        <footer class="footer">
            <p>Generated on September 24, 2025 at 07:19 AM</p>
        </footer>
    </div>
</body>
</html>